Pi-toru chewable tablets 500mg from Kissei Pharmaceutical contain sucroferric oxyhydroxide, a phosphate binder effective in controlling serum phosphorus concentrations in patients with chronic kidney disease (YJ code: 2190036F2022, standard: 500mg x 1 tablet).
Pi-toru chewable tablets 500mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
